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The Homeoprotein Nanog Is Required for Maintenance
of Pluripotency in Mouse Epiblast and ES Cells
avoid such ethical issues is to generate pluripotent cells
directly from somatic stem and other cells. The first step
toward this goal is to understand molecular mechanisms
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underlying pluripotency.Mitsuyo Maeda,2 and Shinya Yamanaka1,*
Leukemia inhibitory factor (LIF) has been utilized to1Laboratory of Animal Molecular Technology
maintain the symmetrical self-renewal of mouse ES cellsResearch and Education Center for Genetic
(Smith et al., 1988; Williams et al., 1988). LIF causesInformation
heterodimer formation of the LIF receptor and gp130,Nara Institute of Science and Technology
which resulted in activation of the tyrosine kinase JakNara 630-0192
(Ernst et al., 1996). The activated Jak phosphorylatesJapan
several tyrosines of gp130, which serve as docking sites2 First Department of Anatomy
for proteins containing Src homology 2 (SH2) domains,Osaka City University Medical School
including the signal transducer and activator of tran-Osaka 545-8585
scription (Stat) family of transcription factors (Ihle, 1996).Japan
Multiple lines of evidence indicated that Stat3 is the
key downstream transcription factor of the LIF/gp130
pathway in ES cells. Forced expression of a dominant-Summary
negative Stat3 mutant caused differentiation of ES cells
even with the presence of LIF (Niwa et al., 1998). PointEmbryonic stem (ES) cells derived from the inner cell
mutation of the tyrosine residue of gp130 responsiblemass (ICM) of blastocysts grow infinitely while main-
for the Stat binding abrogated the ability of LIF to main-taining pluripotency. Leukemia inhibitory factor (LIF)
tain self-renewal, while other tyrosines were dispens-can maintain self-renewal of mouse ES cells through
able (Ernst et al., 1999; Matsuda et al., 1999). ES cellsactivation of Stat3. However, LIF/Stat3 is dispensable
expressing a fusion molecule consisting of Stat3 andfor maintenance of ICM and human ES cells, sug-
estrogen receptor could be maintained pluripotent bygesting that the pathway is not fundamental for pluri-
the estrogen derivative tamoxifen (Matsuda et al., 1999).potency. In search of a critical factor(s) that underlies
Gene targeting experiments also demonstrated the im-pluripotency in both ICM and ES cells, we performed in
portance of Stat3 for ES cell self-renewal (Raz et al.,silico differential display and identified several genes
1999).specifically expressed in mouse ES cells and preimplan-
However, mutant embryos deficient in the LIF/gp130/tation embryos. We found that one of them, encoding
Stat3 pathway apparently form normal ICM; LIF-defi-the homeoprotein Nanog, was capable of maintaining
cient mice develop normally (Stewart et al., 1992), whileES cell self-renewal independently of LIF/Stat3. na-
LIF receptor-deficient mice showed perinatal lethalitynog-deficient ICM failed to generate epiblast and only
(Li et al., 1995; Ware et al., 1995). Embryos deficient inproduced parietal endoderm-like cells. nanog-defi-
gp130 progressively die between 12.5 days postcoitumcient ES cells lost pluripotency and differentiated into
(dpc) and term (Yoshida et al., 1996). Stat3-deficientextraembryonic endoderm lineage. These data dem-
embryos developed into the egg cylinder stage untilonstrate that Nanog is a critical factor underlying pluri-
embryonic day (E)6.0 and showed a rapid degenerationpotency in both ICM and ES cells.
between E6.5–E7.5 (Takeda et al., 1997). A role of LIF/
gp130 in preimplantation embryos is evident only forIntroduction
prolonged survival of blastocysts during diapause (Nich-
ols et al., 2001). Furthermore, LIF is not required for self-
Embryonic stem (ES) cells derived from inner cell mass renewal of human ES cells (Reubinoff et al., 2000) and
of mammalian blastocysts grow rapidly and infinitely several mouse ES cell lines (Berger and Sturm, 1997;
while maintaining pluripotency, the ability to differenti- Dani et al., 1998). In addition, Stat3 is expressed in wide
ate into all types of cells (Evans and Kaufman, 1981; ranges of cell types and, in some cases, is essential
Martin, 1981). These properties of ES cells are main- for differentiation (Nakajima et al., 1996). These results
tained by symmetrical self-renewal, producing two iden- argue that LIF/gp130/Stat3 are not fundamental for pluri-
tical stem cell daughters upon cell division (Burdon et potency and predict the existence of a novel pathway(s)
al., 2002). These properties have raised the hope that that maintains pluripotency in both ICM and ES cells.
ES cells could be used to treat a host of degenerative Several transcription factors have been shown essen-
diseases such as Parkinson’s disease and diabetes tial for pluripotency in ICM, but none of them function
(Smith, 1998). This hope was accelerated by the genera- independently of LIF/Stat3. Oct3/4 is a POU family tran-
tion of pluripotent cells from human blastocysts (Thom- scription factor specifically expressed in ES cells, preim-
son et al., 1998). However, human ES cells also raised plantation embryos, epiblast, and germ cells (Okamoto
substantial ethical issues since human embryos have et al., 1990; Scholer et al., 1990). Inactivation of oct3/4
to be destroyed to generate ES cells (Colman and Burley, in embryos and ES cells resulted in loss of pluripotency
2001; Lachmann, 2001; Mieth, 2000). One solution to and spontaneous differentiation into trophoblast lineage
(Niwa et al., 2000). However, ES cells expressing Oct3/4
constitutively from an exogenous promoter still required*Correspondence: shinyay@gtc.aist-nara.ac.jp
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Table 1. Top 20 Genes with Highest Enrichment in ES Cells Identi-
fied by Digital Differential Display
Frequency Frequency
Unigene ES/EC cell Others Symbol
Mm.139314 0.00295 0 ecat2
Mm.10205 0.0028 0 utf1
Mm.5090 0.00079 0 cripto
Mm.157658 0.00076 0 ecat1
Mm.46472 0.00076 0 hnRNB-G
Mm.5180 0.00073 0 Nr0b1/dax-1
Mm.6047 0.00067 0 ecat4/nanog
Mm.28369 0.00049 0 ecat3/fbx15
Mm.17031 0.0004 0 oct3/4
Mm.3396 0.00033 0 Zfp42/rex1
Mm.45676 0.00033 0 EST
Mm.249524 0.00033 0 ecat5/ERas
Mm.23310 0.0003 0 zfp296
Mm.18154 0.00027 0 tcl1
Mm.13433 0.00027 0 ecat7
Mm.47904 0.00027 0 ecat8
Mm.4213 0.00024 0 ecat9
Mm.913 0.00024 0 brachyury (T )
Mm.28388 0.00024 0 tex20
Mm.158190 0.00021 0 ecat6
LIF for self-renewal (Niwa et al., 2000). Overexpression
of oct3/4 induced differentiation similar to that caused
Figure 1. Northern Blot Analyses of ecat Genesby stat3 inactivation, indicating crosstalk between the
Five micrograms of total RNA was analyzed with mouse cDNAs oftwo transcription factors. Two other transcription fac-
each ecat and H-ras as probes. Differentiation of ES cells was in-
tors, Sox2 (Avilion et al., 2003) and FoxD3 (Hanna et al., duced with retinoic acid (3  107 M) for 5 days.
2002), were recently shown essential for pluripotency
in embryos. Since both Sox2 and FoxD3 cooperatively
LIF-Independent Self-Renewal by Ecat4/Nanog
function with Oct3/4 (Guo et al., 2002; Yuan et al., 1995),
We expressed ecat, oct3/4, or sox2 constitutively in ES
it is likely that they also have crosstalk with Stat3.
cells to explore their ability to render ES cells indepen-
The purpose of this study is to identify the LIF/Stat3-
dent of LIF for self-renewal. To this end, we utilized the
independent factor(s) that underlies pluripotency in both supertransfection system, in which more than 90% of
ICM and ES cells. To this end, we conducted digital transfected cells expressed the gene of interest,
differential display to identify genes expressed in ES allowing functional analyses of polyclonal population
cells as specifically as oct3/4. We explored functions of (Aubert et al., 2002; Niwa et al., 2002). As has been
these genes by constitutive expression in ES cell and reported, forced expression of Oct3/4 resulted in differ-
targeted gene disruption. Here, we report that one of entiation of ES cells (data not shown). Ecat9 and Sox2
them, which we now call Nanog for Tir Na Nog (land of induced massive cell death. We were able to establish
the ever young), maintains pluripotency of both ICM and cells constitutively expressing the other eight Ecats.
ES cells independently of LIF/Stat3. When cultured with LIF, all of them showed normal mor-
phology. When cultured without LIF, all but one differen-
tiated normally as judged by flattened morphology (Fig-
Results ure 2A) and reduced oct3/4 expression (Figure 2B). In
contrast, cells constitutively expressing ecat4 did not
Identification of ecat by Digital Differential Display show such a morphological change even after pro-
To identify candidates of the LIF/Stat3-independent fac- longed culture (1 month) without LIF (Figure 2A). Ex-
tor(s) essential for pluripotent cells, we performed digital pression of oct3/4 also remained normal (Figure 2B).
differential display (http://www.ncbi.nlm.nih.gov/UniGene/ Because of this unique property, we renamed ecat into
info_ddd.shtml) to compare expressed sequence tag nanog from Tir Na Nog (land of the ever young).
(EST) libraries from mouse ES cells and those from vari- These (CAG-nanog) cells expressed significantly more
ous somatic tissues. A number of genes were found nanog transcripts (Figure 2B) and proteins (Figure 2C)
overrepresented in ES cell-derived libraries (Table 1). than control cells. The nanog expression sustained even
Among twenty genes with highest enrichment were after prolonged culture without LIF. Stat3 activation ki-
oct3/4, utf1 (Okuda et al., 1998), and rex1 (Rogers et al., netics was unchanged (Figure 2D). Growth speed was
1991), which had been experimentally identified as ES faster than control cells but significantly decreased by
cell-specific markers. Northern blot analyses confirmed LIF removal (Figure 2E). These data demonstrated that
ES cell-specific expression in nine uncharacterized genes constitutive expression of Nanog maintains the undiffer-
(Figure 1). We designated these genes ecat, for ES cell entiated state of ES cells independently of the LIF/Stat3
pathway.associated transcripts.
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Figure 2. Forced Expression of Nanog from a Constitutive Promoter
(A) Morphology of MG1.19 cells transfected with the parent plasmid (mock) or the Nanog expression vector (CAG-nanog). Cells were grown
with or without LIF for three passages after puromycin selection.
(B) Expression levels of nanog, oct3/4, and nat1 in cells described in (A) were determined by RT-PCR.
(C) Lysates were isolated from cells described in (A) and blotted with -Nanog antiserum or -Cdk4 antibody (Santa Cruz, sc-260-G). Lower
bands detected by -Nanog antiserum are likely originated from proteolytic products.
(D) LIF was removed for 60 min and was added back to culture medium. Cell lysates were collected at the indicated time points and blotted
with -Nanog antiserum, -Oct3/4 antibody (Santa Cruz, sc-5279), -phospho-Stat3 (Tyr705) antibody (Cell Signaling Technology, #9131),
and -Stat3 antibody (Santa Cruz, sc-482).
(E) Cells (10,000 cells per well of 24-well plates) were cultured with or without LIF for 5 days and cell numbers were counted. Shown are
averages and standard deviations of four independent experiments.
A Unique Homeoprotein Encoded by nanog region of 1077 nt containing a B2 repetitive element
(data not shown). Homology search revealed that theThe nanog cDNA consisted of 2184 nucleotides (nt) and
contained a single open reading frame encoding poly- predicted Nanog protein contains a homeobox domain
(Figure 3A). Phylogenic analysis showed that the Nanogpeptide of 305 amino acids. It has a long 3 untranslated
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Figure 3. Sequence and Expression of Nanog
(A) Amino acid sequence of mouse Nanog is
compared with human hypothetical protein
FLJ12581 and mouse Nkx-2.3. Homeodo-
mains are shown by closed boxes, in which
numbers indicate amino acid identity with Na-
nog. Also shown are Trp repeat, TN domain,
and NK2-SD domain. Tyrosine shown is
strictly conserved among homeodomains of
the NK-2 family, but not in Nanog or
FLJ12581.
(B) RT-PCR analysis showing expression pro-
files of mouse nanog, oct3/4, and nat1. Lanes:
1, undifferentiated MG1.19 ES cells; 2, differ-
entiated MG1.19 ES cells; 3, undifferentiated
RF8 ES cells (RT minus control); 4, undifferen-
tiated RF8 ES cells; 5, differentiated MG1.19
ES cells; 6, brain; 7, heart; 8, kidney; 9, testis;
10, spleen; 11, muscle; 12, lung; 13, stomach;
14, ovary; 15, thymus; 16, liver; and 17, skin.
(C) Lysate was collected from four ES cell
lines, maintained undifferentiated (indicated
by U) or treated with retinoic acid for 5 days
(indicated by D). Western blot was performed
with -Nanog antiserum or -Cdk4 antibody.
homeobox is most similar to those of the Nk-2 gene et al., 1990) (Figure 3C). Retinoic acid treatment de-
creased Nanog protein levels in all four lines. Recently,family (Harvey, 1996). However, the amino acid identity
is less than 50%. Furthermore, Nanog has valine at the Wang et al. (2003) reported the identification and expres-
sion analysis of the same gene as nanog. Consistentposition corresponding to tyrosine strictly conserved
among the NK-2 family. The TN domain and the NK-2- with our data, they demonstrated specific expression in
ES cells and preimplantation embryos. DNA microarraysspecific domain, which are also conserved among the
NK-2 family, do not exist in Nanog. These data indicate analyses demonstrated that nanog is expressed in ES
cells, but not in neural or hematopoietic stem cells (Ra-that Nanog is distinct from the NK-2 family. Amino acid
identities of the Nanog homeodomain with other homeo- malho-Santos et al., 2002).
Database analyses showed that the human hypotheti-proteins expressed in ES cells, namely Oct3/4, Pem (Fan
et al., 1999), and Ehox (Jackson et al., 2002), are less cal protein FLJ12581 is most similar to Nanog (Figure
3A). Although overall amino acid identity is relativelythan 20% (data not shown). However, Nanog is identical
to a homeodomain protein recently described as being low (52%), its homeodomain is 85% identical to mouse
Nanog. FLJ12581 also contains Trp-rich repeats, inexpressed selectively in ES cells (Wang et al., 2003).
Nanog also contains a stretch of sequence in which Trp- which Typ-X-X-X is repeated eight times. In addition,
FLJ12581 contains an Alu repetitive element in the 3X-X-X is repeated ten times in tandem. The function(s)
of the Trp-rich repeats is not known. untranslated region. FLJ12581 is located on chromo-
some 12, the syntenic region of mouse chromosome 6Transcripts of nanog were not detectable in twelve
somatic organs, including testis and ovary, by either where nanog is located. Blast search against the human
dbEST identified EST clones corresponding to FLJ12581Northern blot (Figure 1) or RT-PCR (Figure 3B). Western
blot with -Nanog rabbit antiserum, which we raised in libraries from NT2 human teratocarcinoma cells, germ
cell and testis tumors, marrow, and other tumors. Noagainst histidine-tagged Nanog protein, detected a spe-
cific band of expected size (35 kDa) in four independent EST clones was detected in libraries from normal so-
matic tissues except those corresponding to the AluES cell lines: RF8 (Meiner et al., 1996), MG1.19 (Gass-
mann et al., 1995), J1 (Li et al., 1992), and CGR8 (Nichols element. Northern blot analysis did not detect FLJ12581
Stat3-Independent Pluripotency Maintenance Factor
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transcripts in 12 adult organs (data not shown). These (Palmieri et al., 1994). When cultured without feeder
cells, oct3/4 and rex1 were eliminated, while gata6 wasdata indicate that FLJ12581 is the human nanog or-
tholog. further induced (data not shown) consistent with their
parietal endoderm-like morphology (Figure 5A). These
data indicated that nanog disruption specified ES cellTargeted Disruption of the Mouse nanog Gene
fate exclusively into extraembryonic endoderm lineages.in ES Cells
Analysis with mouse genome databases demonstrated
Establishment of nanog-Deficient Micethat the nanog gene consisted of four exons. We gener-
To study in vivo function(s) of Nanog, we injected geoated two targeting vectors that replaced the homeodo-
heterozygous ES cells into C57BL/6 blastocysts. Germ-main with either a fusion of -galactosidase and the
line transmission was obtained from three independentneomycin-resistance gene (geo) (Mountford et al.,
ES clones. Heterozygous mutant mice were normal in1994) or the hygromycin-resistant gene (hygr) (Figure
gross appearance and fertile (data not shown). X-Gal4A). These vectors were introduced into RF8 ES cells
staining of the preimplantation embryos detected geoby electroporation, and drug-resistant colonies were
expression in the inner cell mass of blastocysts and thescreened for homologous recombination. With the geo
central portion of the morula, but not in 32-cell stage ortargeting vector, 27 out of 96 colonies were found posi-
earlier embryos (Figure 6A).tive by PCR (data not shown). With the hygr vector, 8 out 27
were positive. Homologous recombination was confirmed
with Southern blot (Figure 4B) and PCR (Figure 4C). X-Gal Lack of Epiblast in nanog Null Embryos
staining of heterozygous ES cells confirmed that nanog Among 231 mice born from heterozygous intercrosses,
is expressed in all undifferentiated ES cells but re- 80 were wild-type and 151 were heterozygous. Since
pressed by retinoic acid treatment (Figure 4E). no homozygous offspring was obtained, we analyzed
To obtain homozygous mutant ES cells, we intro- embryos of various stages. Among 36 decidual swellings
duced the hygr vector into heterozygous clones estab- obtained at 7.5 dpc, 14 contained wild-type embryos
lished by the geo vector. In 34 out of 83 hyg-resistant and 16 contained heterozygous mutants. Six deciduae
clones, homologous recombination of the hygr vector were empty. We therefore histologically examined E5.5
was confirmed. Among these, 11 clones were found embryos. Of 33 embryos examined, 26 showed normal
homozygous for nanog mutation by Southern blot (Fig- morphology (Figure 6B). However, seven embryos ap-
ure 4B) and PCR (Figure 4C). Northern blot (Figure 4D) peared to consist entirely of disorganized extraembry-
and Western blot (data not shown) analyses confirmed onic tissues with no discernible epiblast or extraembry-
the absence of expression in homozygous cells. In the onic ectoderm. The high incidence (7 out of 33) indicates
other 23 clones, the hygr vector replaced the geo cas- that these abnormal embryos are nanog null. They are
sette. We also introduced the geo vector into heterozy- different from foxD3 null embryos that do have epiblast
gous clones established by the hygr vector. In 114 out at this stage (Hanna et al., 2002) and Sox2 null embryos
of 397 G418-resistant clones, homologous recombina- that lack epiblast but showed expansion of extraembry-
tion of the geo vector was confirmed. Among these, onic ectoderm (Avilion et al., 2003).
six clones were found homozygous. Cells deficient in At 3.5 dpc, we found that 3 out of 15 blastocysts
nanog obtained by both orders showed identical pheno- were homozygous and indistinguishable from normal
types. embryos. When cultured on gelatin-coated plate, how-
ever, ICM of nanog null blastocysts failed to proliferate
(Figure 6C). To further clarify the fate of mutant ICM, weLoss of Pluripotency and Extraembryonic Endoderm
removed trophectoderm by immunosurgery. ICM defi-Differentiation in nanog Null Cells
cient in nanog did not persist as undifferentiated massesCells deficient in nanog were distinct in morphology
in vitro but differentiated completely into parietal endo-from wild type and heterozygous ES cells. When main-
derm-like cells within 4 days (Figure 6D). In contrast totained on STO feeder cells, they were larger and round-
oct3/4 null ICM (Nichols et al., 1998), no trophoblastshaped (Figure 5A); when cultured without feeder cells,
differentiation was observed. These data demonstratedthey further flattened and showed parietal endoderm-
that Nanog is essential for maintenance of pluripotencylike morphology. Cells deficient in nanog grew signifi-
of ICM at a stage after the initial requirement for Oct3/4.cantly slower that heterozygous ES cells (Figure 5B) but
could be serially passaged for at least 2 months (data
not shown). Identification of DNA Recognition Sequence
of NanogNorthern blot (Figure 5C) and RT-PCR (Figure 5D)
analyses showed that nanog null cells expressed a num- We determined DNA recognition sequence of Nanog by
systematic evolution of ligands by exponential enrich-ber of endoderm transcription factors, parietal endoderm
markers, and visceral endoderm markers. In contrast, ment (SELEX). By selecting random olionucleotide with
the fusion protein consisting of maltose binding proteinmesoderm marker brachyury (t ), trophoblast marker
cdx2, primitive ectoderm marker fibroblast growth fac- (MBP) Nanog fusion proteins (see Experimental Proce-
dures for details), we identified a consensus sequencetor (fgf)-5, or the neuroectodermal marker islet-1 (isl1)
were not induced. Pluripotent cell markers oct3/4 and (C/G)(G/A)(C/G)C(G/C)ATTAN(G/C) (Figure 7A). The high-
est conservation was observed with the tetramer ATTA,rex1 were greatly reduced though not completely elimi-
nated when cultured on STO feeder cells. The persis- which is common for DNA recognition sequences of
many homeobox transcription factors. This consensustence of low oct3/4 expression may be related to its
proposed role in primitive endoderm specification sequence is different from that of the NK-2 family, T(C/T)
Cell
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Figure 4. Targeted Disruption of the Mouse nanog Gene
(A) Structures of the mouse nanog gene, targeting constructs, and correctly targeted loci. Positions of the probe and ScaI recognition sites
(S) used for Southern blot were shown. Arrows indicate primers for PCR analyses.
(B) Southern blot with the 3 probe produced an 11 kb band from the wild type locus, a 15.4 kb band from the geo-targeted locus, and a
7.3 kb band from the hygr targeted locus.
(C) Specific amplification by PCR with primers 6047-insS1.2 (CACCTACCACCATGCCAGGCTGAGAATGTC) and 6047-RACE1 (AGCTGGCATCG
GTTCATCATGGTACA) produced a 3.2 kb band from the wild type locus, an 8.5 kb band from the geo targeted locus, and a 4.2 kb band
from the hygr targeted locus.
(D) Northern blot analysis confirmed the absence of nanog transcripts in knockout cells.
(E) X-Gal staining of geo/ ES cells that were maintained undifferentiated on STO cells or induced to differentiate by retinoic acid (RA).
AAGTG (Harvey, 1996), consistent with the amino acid Discussion
differences between Nanog and NK-2. Gel-mobility shift
assay showed that mobility of consensus oligonucleo- Prior to this study, LIF/gp130/Stat3 was the only known
biochemical pathway that could maintain self-renewaltides was retarded by extracts of F9 embryonic carci-
noma cells (Figure 7B) and RF8 ES cells (data not of mouse ES cells (Burdon et al., 2002). However, LIF/
gp130/Stat3 is dispensable for development of ICM andshown). The shift in mobility was abolished by excess
amount of unlabeled consensus oligonucleotides, but self-renewal of human ES cells, suggesting that this
pathway is not fundamental for pluripotency (Nicholsnot by those with mutations in ATTA.
Stat3-Independent Pluripotency Maintenance Factor
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Figure 5. Analyses of nanog Null Cells
(A) Morphology of wild type RF8 cells grown on STO feeder cells (WT) and nanog null cells (KO) grown with or without STO feeder cells.
(B) Three clones of heterozygous cells (/) and homozygous cells (/) were plated at 1  104 cells per well of 24-well plates. Cell numbers
were counted after 2, 4, and 6 days.
(C) Total RNA was isolated from parent RF8 cells (WT), four clones with random integration of the geo vector (/), four heterozygous clones
(/), and four homozygous clones (/). Expression of marker genes was determined by Northern blot analyses.
(D) Total RNA was isolated from wild-type RF8 cells (nanog, WT), nanog null cells (nanog, KO), ZHBTc4 cells (Niwa et al., 2000) cultured
without tetracycline (oct3/4, WT), and ZHBTc4 cells cultured with tetracycline for 96 hr, which differentiated into trophoblast (oct3/4, KO).
Expression of marker genes was determined by RT-PCR.
et al., 2001). In this study, we demonstrated that the resulted in loss of pluripotency in both ICM and ES cells.
In the accompanying paper, Chambers et al. showedhomeoprotein Nanog can maintain self-renewal of ES
cells independently of the LIF/gp130/Stat3 pathway. that Nanog has an ability to maintain not only undifferen-
tiated state, but also pluripotency independently of LIFFurthermore, we showed that deletion of the nanog gene
Cell
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Figure 6. Analyses of nanog Null Embryos
(A) X-Gal staining of preimplantation embryos obtained from intercross of heterozygous geo mice.
(B) Decidual swellings obtained from heterozygous intercross were removed from uterus, fixed with 10% buffered formalin, and embedded
in paraffin. Sections (5 m each) were stained with hematoxylin and eosin.
(C) Blastocysts obtained from heterozygous intercrosses were grown on gelatin-coated plate with ES cell medium. After 10 days, morphology
was recorded and genotype was determined by PCR. All homozygous blastocysts showed similar morphology shown here.
(D) ICM isolated by immunosurgery was cultured in vitro for 4 days.
Stat3-Independent Pluripotency Maintenance Factor
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function phenotypes in ES cells are different between
Stat3 and Nanog. Inactivation of the Stat3 pathway by
LIF depletion or a dominant-negative mutant resulted
in differentiation into multiple cell lineages including
primitive endoderm and mesoderm (Niwa et al., 1998).
However, terminal differentiation into parietal and/or vis-
ceral endoderm was not observed. Expression of gata4
and gata6 was barely increased by those treatments
(Fujikura et al., 2002). In contrast, nanog null cells spon-
taneously differentiated into parietal and visceral endo-
derm expressing high levels of gata4 and gata6. Third,
LIF was still able to enhance growth of CAG-nanog cells.
If Nanog were a downstream target of Stat3, these re-
sults could not be explained.
How does Nanog maintain self-renewal of ES cells?
One of the mechanisms may be transcriptional repres-
sion of genes that promote differentiation, such as gata4
and gata6. We found that both gata4 and gata6 were
upregulated in nanog null cells. Forced expression of
gata4 or gata6 in ES cells was sufficient to induce extra-
embryonic endoderm differentiation (Fujikura et al.,
2002). Expression patterns of marker genes were nearly
identical between their gata6-overexpressing cells and
our nanog null cells. Therefore, the upregulation of gata4
and gata6 could be sufficient to explain spontaneous
differentiation into extraembryonic endoderm in nanog
null cells.Figure 7. DNA Recognition and Proposed Functions of Nanog
It has been shown that gata6 may be upstream of
(A) Consensus binding sequence was determined by SELEX and
gata4, since inactivation of gata6 resulted in repressionshown with Sequence logo (Schneider and Stephens, 1990), which
of gata4 (Morrisey et al., 1998) while inactivation of gata4was generated by WebLogo (www.bio.cam.ac.uk/cgi-bin/seqlogo/
increased gata6 expression (Kuo et al., 1997). We foundlogo.cgi). The height of each letter is proportional to its frequency,
and the letters are sorted so that the most common one is on top. that the gata6 enhancer region (Molkentin et al., 2000;
The height of the entire stack is adjusted to signify the information Sun-Wada et al., 2000) contains the DNA recognition
content (measured in bits) of the sequence at that position. motif of Nanog determined by SELEX, suggesting that
(B) 32P-labeled oligonucleotides containing the consensus sequence
Nanog might directly repress gata6, thereby inhibiting(wt: tgaggcccaccctCAGCCATTAaCctttttactttattct) or mutated se-
ES cell differentiation. In addition, the Nanog consensusquence (mut: tgaggcccaccctCAGCCAGGAaCctttttactttattct) were
sequence is found in the enhancer region of rex1 (Ben-incubated with nuclear extracts of F9 embryonic carcinoma cells,
separated by SDS-PAGE, and visualized by a phosphoimager (Toku- Shushan et al., 1998). Thus, Nanog may also regulate
zawa et al., 2003). Specificity of the reaction was tested by addition ES cell-specific genes to maintain pluripotency. Further
of excess amount of cold oligonucleotides. studies, such as reporter gene assays and gel-mobility
(C) Proposed functions of Nanog, Oct3/4, and Stat3 in preimplanta- shift assays, are required to determine whether Nanog
tion embryos (upper) and ES cells (lower).
indeed binds to the consensus sequence in the gata6
or rex1 to regulate their expression.
Another important issue is the relationship between
(Chambers et al., 2003 [Cell, this issue]). These data Nanog and Oct3/4. The loss-of-function phenotypes of
argue that Nanog is the missing fundamental factor that the two transcription factors are different. Disruption
underlies pluripotency in both ICM and ES cells. of nanog resulted in cell populations that expressed
The ability to support LIF/Stat3-independent self- markers of both parietal and visceral endoderm and
renewal is unique to Nanog. We identified eight other could be serially passaged for several months. In con-
ecat genes that are expressed in ES cells as specifically trast, oct3/4 null cells differentiated into trophectoderm
as nanog and oct3/4. We have shown that ecat3 encod- (Nichols et al., 1998; Niwa et al., 2000). Overexpression
ing the F box protein Fbx15 is a novel target of Oct3/4 phenotypes are also different. Overexpression of nanog
and Sox2 (Tokuzawa et al., 2003). We have also demon- led to LIF-independent self-renewal of ES cells, while
strated that ecat5 encoding a constitutively active Ras oct3/4 overexpression resulted in differentiation into
protein (ERas) plays an important role in tumor-like prop- multiple cell lineages, a similar phenotype caused by
erty of ES cells (Takahashi et al., 2003). However, we Stat3 inactivation (Niwa et al., 2000). These results indi-
could not achieve LIF/Stat3-independet self-renewal cate that the primary function of Oct3/4 is to prevent
with Ecat3, Ecat5, other Ecats, Oct3/4, or Sox2. These trophectoderm differentiation of ICM and ES cells. In
results highlighted the importance of Ecat4/Nanog in contrast, Nanog independently prevents differentiation
maintenance of pluripotency. into extraembryonic endoderm and actively maintains
Three lines of evidence indicate that Nanog functions pluripotency.
independently of Stat3. First, phosphorylation kinetics of Based on the finding of our present work and previous
Stat3 is not elevated in CAG-nanog ES cells. It responded reports by others, we propose a model for the roles of
Nanog, Oct3/4, and Stat3 in the maintenance of pluripo-normally to LIF removal and stimulation. Second, loss-of-
Cell
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and introduced into RF8 ES cells by electroporation (Meiner et al.,tency (Figure 7C). During preimplantation development,
1996). Genomic DNAs from G418- or hygromycin B-resistant colo-the first cell fate determination takes place at morula
nies were screened for homologous recombination by PCR andstage, when cells remain pluripotent as ICM or differenti-
Southern blot.
ate into trophectoderm. At this stage, nanog expression
is still low and Oct3/4 is the key determinant of cell fate.
Analyses of Marker Gene ExpressionCells that lost oct3/4 expression differentiate into troph-
Total RNA was isolated with Trizol (Invitrogen). Northern blot analy-
ectoderm. ses were performed with formalin-agarose gel as previously de-
The second cell fate determination subsequently scribed (Yamanaka et al., 2000, 1998). For RT-PCR, first strand cDNA
takes place at blastocyst stage when cells of ICM remain was synthesized with ReverTra Ace (Toyobo, Japan), and PCR was
carried out with ExTaq (Takara, Japan). Most PCR primers werepluripotent as epiblast or differentiate into primitive en-
described by others (Fujikura et al., 2002). Other primers used aredoderm. Nanog is expressed at this stage and functions
6047-S4 (AGGGTCTGCTACTGAGATGCTCTG) and 6047-AS5 (CAACas the crucial determinant of cell fate. Cells that express
CACTGGTTTTTCTGCCACCG) for nanog, Oct3/4-U474 (CTGAGGG
nanog remain pluripotent, while cells without nanog dif- CCAGGCAGGAGCACGAG) and Oct3/4- L935 (CTGTAGGGAGGGC
ferentiate into primitive endoderm. TTCGGGCACTT) for oct3/4, NAT1-U283 (ATTCTTCGTTGTCAAGC
ES cells derived from ICM require both Oct3/4 and CGCCAAAGTGGAG) and NAT1-L476 (AGTTGTTTGCTGCGGAGTTG
TCATCTCGTC) for nat1, Cdx2-S775 (GGCGAAACCTGTGCGAGTGNanog to prevent differentiation into trophectoderm and
GATGCGGAA) and Cdx2-AS1210 (GATTGCTGTGCCGCCGCCGCTprimitive endoderm, respectively. However, these two
TCAGACC) for cdx2, LimB.S354 (CTGTTCTGAAAGTGAATGTGGTGtranscription factors of normal expression level are not
GCCCC) and LamB-AS945 (GTTTAATCGCCTTCTCTGCTGCAAC
sufficient for ES cell self-renewal. Additional factor(s), CTG) for lamininB1, and TM-S1071 (CCAGGCTCTTACTCCTGTA)
such as Stat3 activated by LIF, are required to support and TM-AS1300 (TGGCACTGAAACTCGCAGTT) for thrombomo-
prolonged maintenance of pluripotency. Increased ex- dulin.
pression of Oct3/4 does not render ES cells independent
of LIF, but instead induces primitive endoderm differen- Isolation of ICM by Immunosurgery
tiation. This suggests that the function of Oct3/4 in ES Blastocysts were incubated for 1 min at room temperature in acidic
Tyrode’s solution (Sigma) to remove Zona Pellucida and washedcells is to specify cell fate into either pluripotent cells
three times with M16 medium (Sigma). Zona-free embryos wereor primitive endoderm by blocking trophectoderm differ-
incubated for 10 min at 37	C with -mouse antiserum (diluted 20entiation. In contrast, our data demonstrated that ele-
times in M16 medium), rinsed three times with M16, and incubated
vated expression of Nanog bypasses the LIF/Stat3 path- for 30 minutes at 37	C with guinea pig complement (ICN Biomedi-
way and maintains self-renewal of ES cells. Thus, Nanog cals, Inc., diluted 20 times in M16 medium). After washing three times
not only blocks primitive endoderm differentiation, but with M16 medium, ICM were isolated from dead trophectoderm and
cultured in gelatin-coated plate with ES cell medium.also actively maintains pluripotency.
In conclusion, our study revealed two important prop-
erties of the homeoprotein Nanog—the fundamental role SELEX
The coding region of the mouse nanog gene was introduced intoin pluripotency of both ICM and ES cells, and the ability
pIH1119 to produce a fusion protein consisting of MBP and Nanog.to maintain ES cell self-renewal without LIF. Oct3/4 and
The fusion was induced in E. coli BL21AI (Invitrogen) and was puri-Stat3, the two well-known players in pluripotency, have
fied with amylose-beads (New England Biolabs). SELEX was per-only one of the two properties. Identification of critical
formed as follows. Double strand oligonucleotide was synthesized
regulatory genes such as nanog is a crucial step in in reaction mixture containing 1 g SELEX-N20-Oligo (TAGGCATGT
understanding early embryogenesis and in exploiting GGATCCGTCTGGCN20GCGTACCGGATCCACCTTCGAT), 1 g
SELEX-N20RV primer (ATCGAAGGTGGATCCGGTACGC), 2.5 lpluripotent cells for therapeutic goals.
10 Klenow buffer, 4 l 10 mM dNTP, and 14.7 l distilled water.
The mixture was denatured at 95	C for 5 min and annealed at 54	CExperimental Procedures
for 5 min. Klenow fragment (0.225 U in 3.6 l of 1 Klenow buffer)
was added to the mixture, which was then incubated at 25	C forConstitutive Expression of the ecat Genes in ES Cells
The coding region of the ecat genes, oct3/4, or sox2 was introduced 40 min. The double-strand DNA was purified by phenol/chloroform
extraction and ethanol precipitation and resuspended in 20 l dis-with Gateway technology (Invitrogen) into pPyCAGIP vector that
allowed episomal expression in MG1.19 ES cells (Aubert et al., 2002; tilled water. DNA-protein binding was performed at 4	C for 30 min
in reaction mixture consisting of 20 l DNA, 30 l MBP-Nanog-Niwa et al., 2002). Transfection into MG1.19 cells was performed with
LipofectAMINE 2000 (Invitrogen) according to the manufacturer’s bound beads, 20 l of 5 binding buffer (100 mM HEPES-KOH [pH
7.9], 1 mM EDTA, 1 M KCl, and 50% Glycerol), and 30 l of water.protocol. Puromycin selection (2 g/ml) was continued throughout
experiments. The beads were washed six times with 100 l lysis buffer (20 mM
Tris-HCl [ph 7.4], 200 mM NaCl, and 1mM EDTA) supplemented
with 1 mM DTT and 0.2 mM PMSF. DNA was purified by phenol/Targeted Disruption of the Mouse nanog Gene
Two targeting vectors with promoter trap selection was designed chloroform extraction and ethanol precipitation and resuspended
in 20 l distilled water. 5 l of this was used for PCR amplificationto replace exon 2 of the mouse nanog gene, which contains the
homeodomain, with an IRES (internal ribosome entry site)-geo cas- in reaction buffer containing 5 l of 10 ExTaq buffer, 4 l of 2.5
mM dNTP, 1 l of 30 M SELEX-N20FW primer (TAGGCATGTGGsette (Mountford et al., 1994) or the IRES-hygr cassette. A 4 kb
fragment containing intron 1 and a 1.5 kb fragment containing exon ATCCGTCTGGC), 1 l of 30 M SELEX-N20RV primer, 0.25 L of
ExTaq polymerase, and 33.75 L of water. PCR program consisted3, intron 3, and exon 4 were amplified from mouse genomic DNA
and used as the 5 and 3 homologous regions of the targeting of the initial denaturation at 95	C for 5 min, 20 cycles of 95	C for 1
min, 54	C for 1.5 min, and 72	C for 1 min, and the final extensionvector. The 5 arm was amplified by expand long template PCR
system (Roche) with primers S4 (AGGGTCTGCTACTGAGATGCTC at 72	C for 7 min. Amplified products were purified by Micro-bio
spin column (BioRad) and concentrated to 20 l by ethanol precipi-TG) and AS4 (AGGCAGGTCTTCAGAGGAAGGGCG). The 3 arm was
amplified with primes IntS3.2 (CGGGCTGTAGACCTGTCTGCATTC tation, of which half was applied to another selection round. This
procedure was repeated five times for enrichment. Amplified prod-TG) and RACE2 (GGTCCTTCTGTCTCATCCTCGAGAGT). Either the
geo or hygr cassette was ligated between the two DNA fragments. ucts in the final reaction were ligated into pCR2.1 vector (Invitrogen).
Thirty clones were randomly selected and sequenced.The resulting targeting vectors were linearized with SacII digestion
Stat3-Independent Pluripotency Maintenance Factor
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